Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FinlandBack to Finland

Clinical trials in Kokkola – page 2

26 clinical trials in Kokkola, Finland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Kokkola at a glance
26
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

26 trials in Kokkola

Open in trial search

Meningococcal infection

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
  • Sponsor:GlaxoSmithKline Biologicals

Influenza immunisation

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)
  • Sponsor:Abbott Biologicals B.V.

Respiratory syncytial virus infection

Not recruiting
Investigational
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:534
  • Sponsor:Sanofi Pasteur Inc.

Meningococcal immunisation

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:TETANUS TOXOID
  • Sponsor:Sanofi Winthrop Industrie

Pneumococcal immunisation

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 1
  • Sponsor:Sanofi Pasteur Inc.

Study on the Safety and Effectiveness of Clesrovimab and Palivizumab for Preventing Severe RSV in Infants and Children at High Risk

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:CLESROVIMAB
  • Sponsor:Merck Sharp & Dohme LLC

Herpes zoster

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Recombinant Varicella Zoster Virus Glycoprotein E
  • Sponsor:GlaxoSmithKline Biologicals

Pneumococcal infection

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal Polysaccharide Serotype 3 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
  • Sponsor:Pfizer Inc.

Meningococcal infection

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur

Influenza+1

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Osivax

Respiratory syncytial virus infection

Not recruiting
Registered drug
Countries:FinlandFinland
  • Participants:0–17 years · Healthy volunteers
  • Sponsor:Merck Sharp & Dohme LLC

Influenza

Not recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Cx-037231
  • Sponsor:Moderna Inc.

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Kokkola

What the registry says about research in the country

01 Respiratory Viral Infections

Extensive research focusing on Respiratory Syncytial Virus (RSV) and influenza prevention through innovative vaccine development. Studies aim to protect both vulnerable populations and healthy adults.

  • RSV vaccines for older adults and infants
  • Influenza vaccine efficacy studies
  • Human Metapneumovirus prevention

Multiple clinical trials evaluating both preventive measures and therapeutic interventions for respiratory infections.

02 Bacterial Infections

Significant developments in preventing meningococcal and pneumococcal infections through advanced vaccine research, particularly focusing on pediatric populations.

  • Meningococcal conjugate vaccines
  • Pneumococcal vaccine studies
  • Long-term immunity evaluation

Research emphasizes vaccine safety and immunogenicity in different age groups.

03 Viral Disease Prevention

Comprehensive studies on Herpes Zoster and Cytomegalovirus prevention, exploring novel vaccine technologies including mRNA platforms.

  • CMV infection prevention
  • Herpes Zoster vaccine efficacy
  • Rhinovirus treatment studies

Focus on developing long-lasting immunity and reducing disease burden in susceptible populations.

04 Cardiovascular Research

Innovative research investigating emergency interventions for acute myocardial infarction, including self-administered treatments.

  • AMI emergency treatment
  • Preventive interventions
  • Patient self-management

Studies aim to improve outcomes in high-risk cardiac patients through rapid intervention strategies.

Back to FinlandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.